News bites: Mergers facing more regulatory roadblocks under Obama


Sen. Charles SchumerCharles SchumerLive Coverage: Senate votes down 'skinny' ObamaCare repeal Passing the DACA legislation will provide relief to children living in fear OPINION | Trump, there is no better AG than Jeff Sessions — don't lose him MORE (D-N.Y.) is pressing for increased regulation of the chemicals used to make the drug ecstasy, according to The Associated Press.

The National Federation of Independent Business (NFIB) is accusing the Environmental Protection Agency (EPA) of bypassing statutory rulemaking requirements in the development of a major new clean water rule, RegWatch reports.

More from RegWatch:

TD Bank agreed to pay financial regulators more than $50 million over charges it took part in a massive Ponzi scheme.

The Nuclear Regulatory Commission (NRC) announced it is moving forward with a study of the cancer risks surrounding U.S. nuclear plants.

The Food and Drug Administration (FDA) issued guidance laying out which smart and tablet apps should be regulated.

A conservative panel decried the federal “food police.”

Environmental Protection Agency administrator Gina McCarthyGina McCarthyIn the fight between Rick Perry and climate scientists — He’s winning Liberal group files lobbying complaint against Pruitt Trump’s budget prioritizes polluters over people MORE warned that a government shutdown would effectively shutter the agency.

Send all of your comments, complaints and regulatory news tips to RegWatch via bgoad@thehill.com or jhattem@thehill.com